SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-012161
Filing Date
2017-03-01
Accepted
2017-03-01 16:37:33
Documents
2
Period of Report
2017-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 v460745_3.html 3  
1 FORM 3 v460745_3.xml 3 6993
2 EXHIBIT 24 v460745_ex24.htm EX-24 6876
  Complete submission text file 0001144204-17-012161.txt   15288
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Kling Douglas F (Reporting) CIK: 0001699022 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38022 | Film No.: 17654717